Evidence map›Paper›PMID 23749747›Full record

ReviewProteomics2013

The Human Eye Proteome Project: perspectives on an emerging proteome.

Richard D Semba, Jan J Enghild, Vidya Venkatraman, Thomas F Dyrlund, Jennifer E Van Eyk

Abstract readReview
In one paragraph

Review in Proteomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Comparisons of the protein expressions between high myopia and moderate myopia on the anterior corneal stroma in human.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  7. Biomarkers of Pediatric Cataracts: A Proteomics Analysis of Aqueous Fluid.International journal of molecular sciences · 2023
    Article
  8. Mass spectrometry-based retina proteomics.Mass spectrometry reviews · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Protein Biomarkers in Uveitis.Frontiers in immunology · 2020
    Review
  16. Review
  17. Article
  18. Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.International journal of molecular sciences · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Richard D SembaWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. rdsemba@jhrmi.edu
Jan J Enghild
Vidya Venkatraman
Thomas F Dyrlund
Jennifer E Van Eyk

Funding

SCLERODERMA-ASSOCIATED PAHP50HL084946 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BLUEMKE, DAVID A. · 2007 to 2011
$20.6M
Oxidative stress and the pathogenesis of sarcopenia and disability in older womenR01AG027012 · NIA · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2005 to 2018
$3.6M
BIGH3 WILD TYPE AND MUTANT PROTEINSR01EY012712 · NEI · DUKE UNIVERSITY · PI KLINTWORTH, GORDON KENNETH · 1999 to 2011
$2.4M
Klotho and the pathogenesis of cardiovascular diseaseR01HL111271 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2012 to 2015
$1.5M
Klotho and cardiovascular disease in the Honolulu Heart ProgramR21HL112662 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2012 to 2013
$237k
NEI NIH HHS R01 EY012712NHLBI NIH HHS P50 HL084946NHLBI NIH HHS R01 HL111271NHLBI NIH HHS R21 HL112662NIA NIH HHS R01 AG027012
6 · The paper itself

Abstract

There are an estimated 285 million people with visual impairment worldwide, of whom 39 million are blind. The pathogenesis of many eye diseases remains poorly understood. The human eye is currently an emerging proteome that may provide key insight into the biological pathways of disease. We review proteomic investigations of the human eye and present a catalogue of 4842 nonredundant proteins identified in human eye tissues and biofluids to date. We highlight the need to identify new biomarkers for eye diseases using proteomics. Recent advances in proteomics do now allow the identification of hundreds to thousands of proteins in tissues and fluids, characterization of various PTMs and simultaneous quantification of multiple proteins. To facilitate proteomic studies of the eye, the Human Eye Proteome Project (HEPP) was organized in September 2012. The HEPP is one of the most recent components of the Biology/Disease-driven Human Proteome Project (B/D-HPP) whose overarching goal is to support the broad application of state-of-the-art measurements of proteins and proteomes by life scientists studying the molecular mechanisms of biological processes and human disease. The large repertoire of investigative proteomic tools has great potential to transform vision science and enhance understanding of physiology and disease processes that affect sight.

Indexed as

Databases, ProteinBiomedical ResearchEyeEye ProteinsHumansProteomeProteomicsEye ProteinsProteomeBiomedicineCorneaEyeRetinaVision

Identifiers

PMID23749747
PMCPMC3978387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.